Department of Radiology, Mayo Clinic Arizona, 13400 E Shea Blvd, Scottsdale, AZ 85259.
Department of Cardiology, Mayo Clinic Arizona, Scottsdale, AZ.
AJR Am J Roentgenol. 2020 Nov;215(5):1208-1217. doi: 10.2214/AJR.20.22790. Epub 2020 Sep 9.
The purpose of this article is to summarize the protocol, interpretation, and diagnostic performance of nuclear medicine and molecular imaging in imaging two distinctive, underdiagnosed cardiomyopathies: cardiac amyloidosis and cardiac sarcoidosis. Emerging new radiotracers and advanced molecular imaging modalities enable us to noninvasively characterize certain types of cardiomyopathies, including cardiac amyloidosis and cardiac sarcoidosis, with great confidence. We expect to improve recognition and promote the application of such advanced techniques in the imaging and management of these potentially lethal cardiomyopathies.
本文旨在总结核医学和分子影像学在两种诊断不足的心肌病——心脏淀粉样变性和心脏结节病的成像中的方案、解读和诊断性能。新兴的放射性示踪剂和先进的分子成像方式使我们能够非常有信心地对某些类型的心肌病，包括心脏淀粉样变性和心脏结节病进行无创特征描述。我们期望提高对这些潜在致命性心肌病的认识，并促进这些先进技术在其成像和管理中的应用。
